Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 1/2018

01-01-2018 | Short Communication

Role of Automated Therapeutic Red Cell Exchange in the Setting of Acute Methemoglobinemia: Our Experience

Authors: Anil Khetarpal, Urvershi Kotwal

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 1/2018

Login to get access

Abstract

Methemoglobinemia, an altered state of hemoglobin resulting in impaired oxygen delivery to the tissues can be congenital or following exposure/ingestion of various oxidant drugs or toxins. One of the earliest signs of methemoglobinemia is generalized cyanosis not improved on oxygen supplementation and presence of normal PO2 on acid blood-gas analysis. Here, we report two cases of acquired methemoglobinemia following poisoning and our experience of managing them with automated therapeutic red cell exchange.
Literature
1.
2.
Saeui C, Charlton N, Brady WJ (2012) Biochemical issues in emergency medicine: diagnostic and therapeutic considerations of selected toxic presentations. Am J Emerg Med 30:231–235CrossRefPubMed
3.
Abu-Laban RB, Zed PJ, Purssell RA, Evans KG (2001) Severe methemoglobinemia from topical anesthetic spray: case report, discussion and qualitative systematic review. CJEM 3(1):51–56CrossRefPubMed
4.
5.
6.
7.
8.
Harvey JW, Keitt AS (1983) Studies of the efficacy and potential hazards of methylene blue therapy in aniline-induced methaemoglobinaemia. Br J Haematol 54(1):29–41CrossRefPubMed
9.
Kearney TE, Manoguerra AS, Dunford JV (1984) Chemically induced methemoglobinemia from aniline poisoning. West J Med 140(2):282–286PubMedPubMedCentral
10.
Senthilkumaran S, Menezes RG, Jena NN, Thirumalaikolundusubramanian P (2013) Methylene blue for refractory anaphylaxis—is it a magic bullet? Am J Emerg Med 31:1140CrossRefPubMed
Metadata
Title
Role of Automated Therapeutic Red Cell Exchange in the Setting of Acute Methemoglobinemia: Our Experience
Authors
Anil Khetarpal
Urvershi Kotwal
Publication date
01-01-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0832-x

Other articles of this Issue 1/2018

Indian Journal of Hematology and Blood Transfusion 1/2018 Go to the issue

Correspondence

Florid Plasmacytosis in Angioimmunoblastic T Cell Lymphoma: A Diagnostic Conundrum

Short Communication

Plasma Cell Dyscrasias in India-2017 Updates

Images

Griscelli Syndrome with Fibronodular Sclerodermatous Chronic Graft Versus Host Disease

Original Article

Lower Transcranial Doppler Flow Velocities in Sickle Cell Anemia Patients on Hydroxyurea: Myth or Fact

Correspondence

Leukocyte Cell Population Data Provide Clues for Myelodysplastic Syndrome in a 79-Year-old Male

Correspondence

Diagnostic Dilemma in Ambiguous Lineage Acute Leukemia: A Case Report
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits